Skip to main content
All lobbying filings

HIMS & HERS HEALTH, INC.

HIMS & HERS HEALTH, INC. filed a Q3 amendment for HIMS & HERS HEALTH, INC. on January 23, 2026.

Lobbying for HIMS & HERS HEALTH, INC. · Telehealth services

All filings by HIMS & HERS HEALTH, INC. · Everything HIMS & HERS HEALTH, INC. has reported

 Filing · LD-2 quarterly report Q3 amendment
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Jan 23, 2026
Expenses
$330,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
California

Official filing document

 Lobbyists on this filing 1
  • WHITNEY JONES New on this filing
    Previously held: Health Policy Analyst, Sen. Rep. Pol. Comm. (2018-2022)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act

 Bills named in this filing 5
  • H.R. 5316
    Drug Shortage Compounding Patient Access Act of 2025
  • H.R. 4605
    End Prescription Drug Ads Now Act
  • H.R. 238
    Healthy Technology Act of 2025
  • S. 5040
    Protecting Patients from Deceptive Drug Ads Online Act
  • S. 2068
    End Prescription Drug Ads Now Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem